ACM
AlphaCrest Capital Management Portfolio holdings
AUM
$1.64B
1-Year Return
23.4%
This Quarter Return
+4.34%
1 Year Return
-23.4%
3 Year Return
-8.44%
5 Year Return
–
10 Year Return
–
AUM
$2.33B
AUM Growth
+$532M
(+30%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
18.17%
Top 10 Holdings %
Top 10 Hldgs %
5.87%
Holding
1,402
New
244
Increased
583
Reduced
375
Closed
199
Top Buys
| 1 |
UnitedHealth
UNH
|
+$11.7M |
| 2 |
Fiserv
FI
|
+$11.3M |
| 3 |
Oracle
ORCL
|
+$11M |
| 4 |
AbbVie
ABBV
|
+$10.4M |
| 5 |
Baxter International
BAX
|
+$10.3M |
Top Sells
| 1 |
Nike
NKE
|
+$18.6M |
| 2 |
Morgan Stanley
MS
|
+$18.5M |
| 3 |
Merck
MRK
|
+$13.4M |
| 4 |
Comcast
CMCSA
|
+$13M |
| 5 |
Microsoft
MSFT
|
+$9.87M |
Sector Composition
| 1 | Technology | 19.24% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 14.37% |
| 4 | Industrials | 13.23% |
| 5 | Consumer Discretionary | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Federal Signal
FSS
$7.65B
| $551K | 0.02% |
13,700
+2,700
| +25% | +$109K |
|
927
Belden
BDC
$5.15B
| $547K | 0.02% |
10,813
+4,735
| +78% | +$240K |
|
928
1-800-Flowers.com
FLWS
$326M
| $545K | 0.02% |
17,100
-78,246
| -82% | -$2.49M |
|
929
Duke Energy
DUK
$94.4B
| $543K | 0.02% |
5,500
+969
| +21% | +$95.7K |
|
930
FNB Corp
FNB
$5.88B
| $543K | 0.02% |
44,008
+29,808
| +210% | +$368K |
|
931
Nutrien
NTR
$27.9B
| $543K | 0.02% |
8,960
-20,240
| -69% | -$1.23M |
|
932
TripAdvisor
TRIP
$2.06B
| $541K | 0.02% |
+13,430
| New | +$541K |
|
933
Northern Trust
NTRS
$24.2B
| $539K | 0.02% |
4,662
-18,503
| -80% | -$2.14M |
|
934
UFP Industries
UFPI
$5.84B
| $538K | 0.02% |
+7,235
| New | +$538K |
|
935
ConocoPhillips
COP
$118B
| $537K | 0.02% |
+8,812
| New | +$537K |
|
936
Southwest Gas
SWX
$5.67B
| $537K | 0.02% |
8,117
-7,439
| -48% | -$492K |
|
937
Five Below
FIVE
$8.05B
| $534K | 0.02% |
2,764
+1,198
| +77% | +$231K |
|
|
FTCH
938
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $534K | 0.02% |
+10,600
| New | +$534K |
|
939
AMN Healthcare
AMN
$751M
| $532K | 0.02% |
+5,485
| New | +$532K |
|
940
Bio-Rad Laboratories Class A
BIO
$7.49B
| $530K | 0.02% |
822
-1,212
| -60% | -$781K |
|
941
Liberty Media Series C
FWONK
$24.7B
| $530K | 0.02% |
+11,373
| New | +$530K |
|
|
RVNC
942
DELISTED
Revance Therapeutics, Inc.
RVNC
| $525K | 0.02% |
17,700
| – | – |
|
943
Whirlpool
WHR
$5.24B
| $523K | 0.02% |
2,401
+943
| +65% | +$205K |
|
|
BCPC
944
Balchem Corporation
BCPC
$5.05B
| $520K | 0.02% |
3,959
+1,759
| +80% | +$231K |
|
|
SWTX
945
DELISTED
SpringWorks Therapeutics
SWTX
| $519K | 0.02% |
+6,300
| New | +$519K |
|
946
Cabot Corp
CBT
$4.21B
| $518K | 0.02% |
9,091
+4,897
| +117% | +$279K |
|
947
ICU Medical
ICUI
$3.3B
| $518K | 0.02% |
2,519
+993
| +65% | +$204K |
|
948
Personalis
PSNL
$478M
| $516K | 0.02% |
+20,400
| New | +$516K |
|
949
Eldorado Gold
EGO
$5.45B
| $515K | 0.02% |
51,807
+31,207
| +151% | +$310K |
|
950
Ziff Davis
ZD
$1.5B
| $511K | 0.02% |
+4,275
| New | +$511K |
|